Patricia J. Zettler is an Associate Professor of Law at The Ohio State University Moritz College of Law, a faculty member of the Drug Enforcement & Policy Center housed at the College of Law, and a Member of The Ohio State University Comprehensive Cancer Center. Professor Zettler’s teaching areas include Torts, Legislation and Regulation, Health Law, and Food and Drug Law.
Professor Zettler’s research focuses on the regulation of medicine, drugs and other medical products, and tobacco products, with an emphasis on the U.S. Food and Drug Administration (FDA). Zettler’s scholarship has appeared or is forthcoming in leading legal, interdisciplinary, and medical journals, such as the Indiana Law Journal, Boston College Law Review, North Carolina Law Review, Journal of Law and the Biosciences, JAMA, JAMA Internal Medicine, EMBO Molecular Medicine, American Journal of Bioethics, and Public Health Reports. She also regularly writes about FDA-related issues at Objective Intent, the FDA law and policy blog that she co-founded, as well as at Stanford’s Law and the Biosciences Blog.
Zettler’s work has earned her recognition, including being selected as a 2015 Health Law Scholar by the American Society of Law, Medicine & Ethics. She also advises various groups and organizations on FDA law and policy. Among other things, she served as a consultant to the National Academies of Sciences, Engineering, and Medicine’s Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse from 2016 to 2017, and has served on the editorial advisory board for the Food and Drug Law Journal since 2015.
Before joining the Ohio State faculty in 2019, Professor Zettler was a faculty member of the Center for Law, Health & Society at Georgia State University College of Law. At Georgia State Law, she was selected as the 2018 winner of the Patricia T. Morgan Award for Outstanding Scholarship among the faculty. Prior to Georgia State, she was a fellow at the Center for Law and the Biosciences at Stanford Law School.
In addition to Professor Zettler’s academic work, she served as an associate chief counsel in the FDA’s Office of the Chief Counsel. In that role, she advised the FDA and the Department of Health and Human Services on various issues including drug safety, human subjects protection, expanded access to investigational drugs, over-the-counter drugs, dietary supplements, prescription drug advertising and promotion, incentives for developing antibiotics, and advisory committees. Professor Zettler also has bioethics experience through work at the Program in Medical Ethics at the University of California San Francisco and at the Department of Bioethics at the National Institutes of Health.
Professor Zettler graduated with distinction from Stanford Law School in 2009. She received a BA in psychology, with distinction and departmental honors, from Stanford University in 2002, where she played on the varsity lacrosse team.